Eli Lilly and Company (NYSE:LLY) Shares Up 0.1% on Analyst Upgrade
Eli Lilly and Company (NYSE:LLY – Get Free Report) traded up 0.1% during mid-day trading on Monday after Truist Financial raised their price target on the stock from $1,029.00 to $1,038.00. Truist ...
Insulin prices are falling due to market forces — no price caps required
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
The Armenian Reporter2d
Top Medical Stocks To Consider – February 03rd
Eli Lilly and Company, UnitedHealth Group, Walmart, AbbVie, and Tempus AI are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer to shares in ...
Twin Cities Business2d
Minnesota AG Reaches Another Insulin Price Cap Settlement
Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...
Insight News2d
Attorney General Keith Ellison secures $35 Novo Nordisk insulin for Minnesotans
For five years, insulin manufacturer Novo Nordisk agrees to cap out-of-pocket cost of its insulin treatments at $35 per month, and provide free insulin to the neediest Minnesotans.
The Armenian Reporter4d
Top Pharmaceutical Stocks To Follow Now – January 31st
AbbVie, Vertex Pharmaceuticals, Eli Lilly and Company, Thermo Fisher Scientific, and Colgate-Palmolive are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.